Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Terumo Corporation (TRUMY)

Other OTC - Other OTC Delayed Price. Currency in USD
28.67-0.30 (-1.04%)
At close: 12:59PM EST
Advertisement

Terumo Corporation

2-44-1, Hatagaya
Shibuya-ku
Tokyo 151-0072
Japan
81 3 3374 8111
https://www.terumo.co.jp

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees28,294

Key Executives

NameTitlePayExercisedYear Born
Mr. Shinjiro SatoPres, CEO & Director702.62kN/A1960
Mr. Toshiaki TakagiChairman & Sr. Managing Exec. OfficerN/AN/A1958
Mr. Naoki MutoChief Accounting & Financial Officer and Exec. OfficerN/AN/AN/A
Fumihisa HiroseGroup Managing Exec. Officer & CTON/AN/AN/A
Mr. Shoji HatanoGroup Sr. Mng. Exe. Off. of Corp. Affairs Dept., Legal and Compliance Dept. & DirectorN/AN/A1959
Mr. Kyo NishikawaGroup Managing Exec. Officer, Chief HR Officer & DirectorN/AN/A1959
Mr. Tsuyoshi TomitaSr. Exec. OfficerN/AN/AN/A
Mr. Hikaru SamejimaGroup Sr. Managing Exec. OfficerN/AN/AN/A
Mr. Kazunori HiroseGroup Managing Exec. Officer, Chief Manufacturing Officer & DirectorN/AN/AN/A
Itaru SakaguchiSr. Exec. OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Corporate Governance

Terumo Corporation’s ISS Governance QualityScore as of October 1, 2022 is 6. The pillar scores are Audit: 4; Board: 6; Shareholder Rights: 6; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement